Formulation and Evaluation of Microsponges Gel of Havan Ash for the Treatment of Acne
The aim of this study was to develop the Microsponges containing Havan ash composed gel formulation for the treatment of Acne. Therefore, the topical formulation containing microsponges of Havan Ash will be formulated and evaluated. The preliminary investigation was carried out for the formulation of Havan ash loaded Microsponges by using quasi emulsion solvent diffusion method (MSF1-MSF6). In the preformulation studies of Havan ash the physical description and organoleptic properties, pH, acid insoluble ash, water-soluble ash, IR spectroscopy, identification test, rheological study, atomic absorption spectroscopy is also carried out. On the basis of particle size analysis of Microsponges, percentage yield formulation MSF5 containing Microsponges formula was selected for composition of topical gel formulation. Thus the different gel base formulation (G1-G3) using Carbopol-934 (1,1.5,2.0%) was prepared by emulsification method. By considering all the relevant, physicochemical parameters, G2 gel base was selected for further loading of Havan ash containing Microsponges. The MSF5 formulation was loaded into the selected gel base G2 (1.5%). Then the formulation and evaluation of Havan ash microsponges loaded gel was done. The formulation F3 has better results than other 4 formulations. F3 have its appearance silver colour, consistency very good, Grittiness –ve, homogeneity good, wash ability very good, pH 6.3, Spreadabilty (g.cm/sec) 14.4 ± 0.77 7and viscosity (cps) 18251 ± 50.12, have good result of psychometric analysis. With the revealed results by different evaluation parameters, it is concluded that microsponges drug delivery system has become highly competitive and rapidly evolving technology and more research are carrying out to optimize cost-effectiveness and efficacy of the therapy.
Keywords: Havan ash, Antimicrobial, Microsponges, Acne vulgaris, Topical gel.
2. Scorer CA. Preclinical and Clinical Challenges in the Development of Disease-Modifying Therapies for Alzheimer's Disease. Drug Discover Today. 2001; 6:1207–1219.
3. Blennow K, De Leon MJ, Zetterberg H. Alzheimer’s Disease. Lancet. 2006; 368:387–403.
4. Tripathi KD. Essentials of Medical Pharmacology. New Delhi: JP Brothers Medical Published. 2010; 123-126.
5. Bansal P, Kaur R, Gupta V , Kumar S And Kaur RP. Is There Any Scientific Basis of Havan to be Used in Epilepsy-Prevention/Cure? 2015 Dec; 5(2):33–45.
6. Rgyan, Hindu Havan – An Ancient Fire Ritual. November 10, 2017.
7. Garg S, Kndarapu R, Kannan V. Pharma. Tech. 2003; 27(2):74.
8. Katsambas A, Papakonstantiou A. Acne: Systemic Treatment. Clin. Dermatol. 2004; 412-418.
9. Nacht S, Kantz M. The Microsponge: A Novel Topical Programmable Delivery System. 1992; 42:299-325.
10. Patel G, Patel JK. Use of A Microsponge in Drug Delivery Systems. IJRPC. 2012; 2(2):237-244
11. Vyas SP, Khar RK. Targeted and Controlled Drug Delivery-Novel Carrier System: New Delhi: CBS Publication, First Edition. 2002; 453.
12. Parikh BN, Gothi GD, Patel TD, Chavda HV, Patel CN. Microsponge as Novel Topical Drug Delivery System. Journal of Global Pharma Technology. 2010; 2(1):17-29
13. D’souza JI, Harinath NM. Topical Anti-Inflammatory Gels of Fluocinolone Acetonide Entrapped in Eudragit Based Microsponge Delivery System. Research J. Pharm. and Tech 2008; 1(4):502-506.
14. Thappa D, Adityan B, Kumari R. Scoring Systems in Acne Vulgaris. Indian J Dermatol Ve. 2009; 75(3):323–326.
15. Benner N, Sammons D. Overview of the Treatment of Acne Vulgaris, Osteopath Family Physic. 2013; 5(5):185–190.
16. Harper JC. Acne Vulgaris, Emedicine. 2009; 649-659.
17. Acne. Mayo Clinic Website. Mayoclinic.Org/Diseases-Conditions/Acne/Symptoms-Causes/Syc-20368047. Accessed March 11, 2018.
18. Maria Julia Bevilaqua Felippe, In Equine Infectious Diseases (Second Edition). 2014; 2:891-898
19. Models for Acne Drug Discoveries & Therapeutics. 2018; 12(6):329-340.
20. Jalian HR, Kim J. In Comprehensive Medicinal Chemistry II. 2007; 22–42.
21. Manandhar NP. Plants and People of Nepal Timber Press, Portland, Oregon USA; 2002; 599.
22. Kim SS, Hyun CG, Lee H., Kim JY. In vitro screening of jeju medicinal plant for cosmeceutical material. J. Appl. Biol. Chem. 2007; 50:215-220.
23. Kumar AS, Baboota SP, Agarwal J. Treatment of acne with special emphasis on herbal remedies, Expert. Rev. Dermotol. 2008; 3:111-122.
24. Shweta K, Swarnlata S. Research journal of medicinal plant. 2011; 5(6):650-669.
25. Osmani RA, Aloorkar NH. Microsponges Based Drug Delivery System for Augmented Gastroparesis Theraphy: Formulation Development and Evaluation. Asian Journal of Pharmaceutical Science. 2015; 10:442-451.
26. Kadam VV, Patel VI, Karpe SM, Kadam VJ. Design, Development and Evaluation of Celecoxib- Loaded Microsponges- Based Topical Gel Formulation. Applied Clinical Research. Clinical Trial and Regulatory Affairs. 2016; 3(1):44-55.
27. Singh R and Jain V. Design and Characterization of Colon Specific Drug Delivery System Containing Paracetamol Microsponges. Arch Pharm Res. 2011; 3(4):733-740.
28. Sharma P. Formulation and Evaluation of Gel-Loaded Microsponges of Roxithromycin for Topical Drug Delivery. IOSR Journal of Pharmacy. 2019; 9(5):14-22.
29. Basha BB, Prakasam K, Divakar G. Formulation and Evaluation of Gel Containing Fluconazole- Antifungal Agent. Int.J.Drug Dev. & Res. 2011; 3(4):109-128.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License. that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).